Literature DB >> 11576295

Plague vaccine research and development.

E D Williamson1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11576295     DOI： 10.1046/j.1365-2672.2001.01497.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN： 1364-5072            Impact factor:   3.772


× No keyword cloud information.
  23 in total

1.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 2.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

4.  Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.

Authors:  Bei Li; Lingxiao Jiang; Qifeng Song; Junxin Yang; Zeliang Chen; Zhaobiao Guo; Dongsheng Zhou; Zongmin Du; Yajun Song; Jin Wang; Hongxia Wang; Shouyi Yu; Jian Wang; Ruifu Yang
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Administration of antibody to the lung protects mice against pneumonic plague.

Authors:  Jim Hill; Jim E Eyles; Stephen J Elvin; Gareth D Healey; Roman A Lukaszewski; Richard W Titball
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.

Authors:  Jeremy L Goodin; David F Nellis; Bradford S Powell; Vinay V Vyas; Jeffrey T Enama; Lena C Wang; Patrick K Clark; Steven L Giardina; Jeffery J Adamovicz; Dennis F Michiel
Journal:  Protein Expr Purif       Date:  2006-12-31       Impact factor: 1.650

7.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

8.  Plague: from natural disease to bioterrorism.

Authors:  Stefan Riedel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

Review 9.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

10.  Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta.

Authors:  Guang Tian; Zhizhen Qi; Yefeng Qiu; Xiaohong Wu; Qingwen Zhang; Xiaoyan Yang; Youquan Xin; Jian He; Yujing Bi; Qiong Wang; Jiyuan Zhou; Yanxiao Fan; Yazhou Zhou; Yongqiang Jiang; Ruifu Yang; Xiaoyi Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.